Björn Krämer

700 total citations
11 papers, 548 citations indexed

About

Björn Krämer is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Björn Krämer has authored 11 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Hematology. Recurrent topics in Björn Krämer's work include Platelet Disorders and Treatments (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Signaling Pathways in Disease (2 papers). Björn Krämer is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Signaling Pathways in Disease (2 papers). Björn Krämer collaborates with scholars based in Germany, United States and Russia. Björn Krämer's co-authors include Meinrad Gawaz, Boris Bigalke, Peter Seizer, Stephan Lindemann, Konstantinos Stellos, Karin Daub, Andreas E. May, Harald F. Langer, Tanja Schönberger and Oliver Borst and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Atherosclerosis.

In The Last Decade

Björn Krämer

11 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Björn Krämer Germany 10 222 180 172 147 129 11 548
Anastasia Abashidze Israel 8 297 1.3× 113 0.6× 103 0.6× 137 0.9× 85 0.7× 8 560
Nagaharu Tsukiji Japan 16 259 1.2× 151 0.8× 252 1.5× 207 1.4× 56 0.4× 29 665
Sanja Ivčević Croatia 13 187 0.8× 162 0.9× 127 0.7× 143 1.0× 80 0.6× 21 511
Sarah Eichenberger United States 4 139 0.6× 93 0.5× 132 0.8× 180 1.2× 45 0.3× 5 481
Elena M. Vasina Germany 6 184 0.8× 118 0.7× 93 0.5× 108 0.7× 70 0.5× 7 393
Kate L. Lowe United Kingdom 12 132 0.6× 194 1.1× 314 1.8× 212 1.4× 57 0.4× 14 589
Maria Rossikhina United States 7 161 0.7× 253 1.4× 167 1.0× 294 2.0× 165 1.3× 7 791
Huimiao Jiang United States 4 224 1.0× 96 0.5× 80 0.5× 248 1.7× 88 0.7× 5 527
Thomas Pap Switzerland 6 246 1.1× 191 1.1× 144 0.8× 64 0.4× 32 0.2× 7 689
Per Reidar Woldbæk Norway 12 277 1.2× 225 1.3× 198 1.2× 85 0.6× 209 1.6× 16 757

Countries citing papers authored by Björn Krämer

Since Specialization
Citations

This map shows the geographic impact of Björn Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Krämer more than expected).

Fields of papers citing papers by Björn Krämer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Krämer. The network helps show where Björn Krämer may publish in the future.

Co-authorship network of co-authors of Björn Krämer

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Krämer. A scholar is included among the top collaborators of Björn Krämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Krämer. Björn Krämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lonsdorf, Anke S., Björn Krämer, Tanja Schönberger, et al.. (2011). Engagement of αIIbβ3 (GPIIb/IIIa) with ανβ3 Integrin Mediates Interaction of Melanoma Cells with Platelets. Journal of Biological Chemistry. 287(3). 2168–2178. 94 indexed citations
2.
Bigalke, Boris, Björn Krämer, Peter Seizer, et al.. (2010). Diagnostic and Therapeutic Potentials of Platelet Glycoprotein VI. Seminars in Thrombosis and Hemostasis. 36(2). 203–211. 10 indexed citations
3.
Daub, Karin, Peter Seizer, Konstantinos Stellos, et al.. (2010). Oxidized LDL-Activated Platelets Induce Vascular Inflammation. Seminars in Thrombosis and Hemostasis. 36(2). 146–156. 64 indexed citations
4.
Langer, Harald F., Konstantinos Stellos, Caroline Steingen, et al.. (2009). Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. Journal of Molecular and Cellular Cardiology. 47(2). 315–325. 67 indexed citations
5.
Seizer, Peter, Tanja Schönberger, Michael Lang, et al.. (2009). EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis. 209(1). 51–57. 96 indexed citations
6.
Bigalke, Boris, Konstantinos Stellos, Dimitrios Stakos, et al.. (2009). Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome. Thrombosis and Haemostasis. 101(5). 911–915. 35 indexed citations
7.
Seizer, Peter, Oliver Borst, Andreas Bültmann, et al.. (2009). EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thrombosis and Haemostasis. 101(4). 682–686. 62 indexed citations
8.
Lindemann, Stephan, Björn Krämer, Karin Daub, Konstantinos Stellos, & Meinrad Gawaz. (2007). Molecular pathways used by platelets to initiate and accelerate atherogenesis. Current Opinion in Lipidology. 18(5). 566–573. 34 indexed citations
9.
Doesch, Christina, Björn Krämer, Tobias Geisler, et al.. (2007). Challenges in the treatment of patients with essential thrombocythemia and acute coronary syndrome. Journal of Thrombosis and Thrombolysis. 25(2). 193–197. 5 indexed citations
10.
Dengjel, Jörn, Maria-Dorothea Nastke, Cécile Gouttefangeas, et al.. (2006). Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas. Clinical Cancer Research. 12(14). 4163–4170. 54 indexed citations
11.
Krämer, Björn, Oliver Schoor, Tobias Krüger, et al.. (2005). MAGED4 – expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue. Cancer Biology & Therapy. 4(9). 943–948. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasia Abashidze Breakdown of academic impact, for papers by Nagaharu Tsukiji Breakdown of academic impact, for papers by Sanja Ivčević Breakdown of academic impact, for papers by Sarah Eichenberger Breakdown of academic impact, for papers by Elena M. Vasina Breakdown of academic impact, for papers by Kate L. Lowe Breakdown of academic impact, for papers by Maria Rossikhina Breakdown of academic impact, for papers by Huimiao Jiang Breakdown of academic impact, for papers by Thomas Pap Breakdown of academic impact, for papers by Per Reidar Woldbæk
Rankless by CCL
2026